Evidence map›Paper›PMID 21075289›Full record

ReviewHematology/oncology clinics of North America2010

Mouse models of inherited cancer syndromes.

Sohail Jahid, Steven Lipkin

Abstract readReview
In one paragraph

Review in Hematology/oncology clinics of North America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sohail JahidDepartment of Biological Chemistry, University of California Irvine, Irvine, CA, USA.
Steven Lipkin

Funding

DNA Mismatch Repair and associated genes in suppression of GI adenomas and carcinR01CA098626 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LIPKIN, STEVEN M · 2004 to 2014
$2.9M
Mechanisms of Notch Signalling in Colon Cancer Initiating CellsR21CA153049 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LIPKIN, STEVEN M · 2010 to 2011
$398k
NCI NIH HHS R01 CA098626NCI NIH HHS R21 CA153049
6 · The paper itself

Abstract

Animal models of cancer have been instrumental in understanding the progression and therapy of hereditary cancer syndromes. The ability to alter the genome of an individual mouse cell in both constitutive and inducible approaches has led to many novel insights into their human counterparts. In this review, knockout mouse models of inherited human cancer syndromes are presented and insights from the study of these models are highlighted.

Indexed as

Disease Models, AnimalAnimalsGenetic Predisposition to DiseaseHumansMiceMice, KnockoutMutationNeoplastic Syndromes, Hereditary

Identifiers

PMID21075289
PMCPMC3011940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.